Clinical toxicology of ‘magic mushroom’ ingestion
Open Access
- 1 September 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 57 (671) , 543-545
- https://doi.org/10.1136/pgmj.57.671.543
Abstract
The clinical features are reported in 27 cases of ‘magic mushroom’ ingestion. Mydriasis and hyperreflexia were common as were disorders of perception and affect. Psilocybe semilanceata appears to have been the species of fungus involved.This publication has 12 references indexed in Scilit:
- Abuse of the mushroom Panaeolus foenisecii.BMJ, 1980
- Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric ComplicationsThe British Journal of Psychiatry, 1978
- The Psilocybin Mushroom PandemicJournal of Psychedelic Drugs, 1975
- Occurrence of psilocybin in the sporophores of Psilocybe semilanceataTransactions of the British Mycological Society, 1969
- COMPARISON OF THREE PSYCHOTROPIC DRUGS (PSILOCYBIN, JB-329, AND IT-290) IN VOLUNTEER SUBJECTSJournal of Nervous & Mental Disease, 1960
- Some observations on psilocybin, a new hallucinogen, in volunteer subjectsComprehensive Psychiatry, 1960
- Experimental Psychiatry. V — Psilocybine, a New Psychotogenic DrugNew England Journal of Medicine, 1960
- DIVISION OF MYCOLOGY: THE HALLUCINOGENIC MUSHROOMS OF MEXICO: AN ADVENTURE IN ETHNOMYCOLOGICAL EXPLORATION*Transactions of the New York Academy of Sciences, 1959
- Comparison of the reactions induced by psilocybin and LSD-25 in manPsychopharmacology, 1959
- Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana HeimCellular and Molecular Life Sciences, 1958